通程控股(000419.SZ)一季度淨利潤預增144.47%-154.65%
格隆匯4月12日丨通程控股(000419.SZ)公佈,預計2022年第一季度歸屬於上市公司股東的淨利潤4800萬元-5000萬元,同比增長144.47%-154.65%;扣除非經常性損益後的淨利潤1780萬元-1850萬元,同比增長0.5%-4.45%。
公司本期淨利潤較上年同期增長的主要原因是公司根據戰略定位,為提升整體經營質量,本期內調整或關閉了部分低效門店。根據新租賃準則的相關規定,對關閉門店的使用權資產、租賃負債以及未攤銷的長期待攤費用進行衝回和攤銷後,增加利潤總額及淨利潤。該事項屬於非經常性損益,影響淨利潤增加2800萬元-3000萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.